One of the most laborious and error-prone tasks in clinical quality reporting may be eliminated by Medisolv’s acquisition of Health Elements AI.
Imagine someone scrolling through pages of patient records, cross-referencing clinical notes, and marking data points that may or may not be clearly documented while seated in a windowless office, or increasingly, a spare bedroom. For thousands of chart abstractors employed by the US healthcare system, this is their everyday reality. It’s labor-intensive, meticulous, and surprisingly delicate work. The high-quality data that hospitals rely on for federal reporting becomes subtly untrustworthy with just one incorrect notation and one omitted field.
That issue has been around for a while. Last month, Medisolv, a healthcare quality company based in Columbia, Maryland, announced that it had purchased Health Elements AI, a startup created especially to automate this process. In the specialized field of clinical quality reporting, the deal carries some weight despite being relatively small in comparison to the large-scale healthcare mergers that dominate financial headlines.
In addition to managing over 140 million patient records and supporting more than 500 quality and safety measures, Medisolv currently collaborates with over 1,800 healthcare organizations. Last year, the company’s more than 4,000 chart abstracters reviewed almost three million cases. This volume helps you understand the scope of the issue as well as the potential if even a small portion of the manual labor can be automated without compromising accuracy.
Although Health Elements AI’s 96% accuracy rate on data abstraction sounds great on paper, it’s important to consider what the remaining 4% actually looks like when it comes to clinical data. Nevertheless, the company’s platform employs AI with human expert oversight layered on top; this combination typically outperforms either pure automation or unassisted human review alone. The honest value is most likely found in that hybrid model.
This acquisition is intriguing because it reveals areas where pressure is increasing in the healthcare industry. The number of high-quality programs is increasing rather than decreasing. Value-based care contracts, accreditation agencies, specialty society registries from organizations like the Society of Thoracic Surgeons and the American College of Cardiology, and CMS requirements all demand organized, validated clinical data more quickly than most hospital teams can reasonably provide it by hand. The already overworked abstractor workforce won’t double in size to satisfy that demand.
It seems that Medisolv considers this acquisition to be more than a simple product addition. The business recently expanded into Medicare Advantage quality programs by acquiring Lilac Software as well. When combined, these actions point to an effort to create a more comprehensive platform that tracks high-quality data from unprocessed clinical records through reporting and submission. Although the operational viability of that vision is still unknown, the strategic reasoning is sound enough to be taken seriously.
The agreement was framed by Health Elements AI CEO Jeff LeBrun as improving clinical data accessibility for teams working on quality and performance. That’s a fair way to describe it. On the ground, this means that abstracters might spend more time doing tasks that genuinely call for human judgment, such as examining edge cases, identifying inconsistencies, and deciphering unclear documentation, rather than searching through discharge summaries. If that change takes place as Medisolv suggests, it could significantly lower reporting errors and burnout.
It’s difficult to ignore the years-long promises made by the healthcare industry to address its data issues. There are records. Clinical notes, scanned PDFs, and incomplete forms all contain the information. The challenging part has always been getting it out consistently. That won’t be fully resolved by this acquisition. However, it’s a legitimate step toward reducing the overall reliance on human endurance.
